Information Library

Results for: Connect with investigators, regulators and physicians - Enrollment & retention - Phase II/III

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Partnering is Key to Maximizing Rewards in Emerging Markets

    Press Release — September 27, 2011 – While biopharmaceutical spending in emerging markets is growing at double-digit rates – much faster than in developed nations – opportunities in “pharmerging” countries must be balanced with accompanying costs and risks of entering new markets.

  • KoNECT & Quintiles Partner to Advance Clinical Research

    Press Release — May 30, 2011 – The Korea National Enterprise for Clinical Trials (KoNECT) and Quintiles have partnered to produce educational events in South Korea for investigators and biopharmaceutical companies.

  • Propelling Pediatric Research

    Case Study — April 1, 2010
    Learn how Quintiles' global reach and rigorous research standards dramatically cut recruitment from 4 years to 1 in a childhood immunology study

  • Alzheimer's Inroads

    Case Study — March 3, 2010
    A global, multi-site Phase III trial required a large number of patients with a specific number of sites and patients at each site.

  • Trumping Expectations

    Case Study — March 1, 2010
    Quintiles sails past recruitment hurdles with tailored approaches that build momentum

Page 1 of 1 (5 results)

Subscribe to Email Based on Your Interests

Set preferences